Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G ROGERS

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Pediatrics|June 1, 1983
Heterogeneity of metatropic dysplasiaM Beck, M Roubicek, J G Rogers, et al.
Journal of Inherited Metabolic Disease|January 1, 1990
Marfan syndrome: absence of type I or III collagen structural defects in 25 patientsV R Harley, D Chan, J G Rogers, et al.
The Journal of Biological Chemistry|March 3, 1995
Type X collagen multimer assembly in vitro is prevented by a Gly618 to Val mutation in the alpha 1(X) NC1 domain resulting in Schmid metaphyseal chondrodysplasiaD Chan, W G Cole, J G Rogers, et al.
Anaesthesia and Intensive Care|August 1, 1996
Anaesthesia for children with mucopolysaccharidosesC Moores, J G Rogers, I M McKenzie, et al.
Teratology|February 1, 1986
Methacrylic acid as a teratogen in rat embryo cultureJ G Rogers, J C Greenaway, P E Mirkes, et al.
Journal of Paediatrics and Child Health|February 1, 1990
Five cases demonstrating the distinctive behavioural features of chromosome deletion 17(p11.2 p11.2) (Smith-Magenis syndrome)A F Colley, M A Leversha, L E Voullaire, et al.
Journal of Inherited Metabolic Disease|January 1, 1985
5,10-Methylenetetrahydrofolate reductase deficiency. Clinical and biochemical features of a further caseE A Haan, J G Rogers, G P Lewis, et al.
Toxicology and Applied Pharmacology|February 1, 1984
Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitroP E Mirkes, J C Greenaway, J G Rogers, et al.
Journal of Medical Genetics|September 1, 1990
The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissuesW G Cole, P E Campbell, J G Rogers, et al.
Journal of Medical Genetics|April 1, 1990
The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagenW G Cole, C W Chow, J G Rogers, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Pediatrics|June 1, 1983
Heterogeneity of metatropic dysplasiaM Beck, M Roubicek, J G Rogers, et al.
Journal of Inherited Metabolic Disease|January 1, 1990
Marfan syndrome: absence of type I or III collagen structural defects in 25 patientsV R Harley, D Chan, J G Rogers, et al.
The Journal of Biological Chemistry|March 3, 1995
Type X collagen multimer assembly in vitro is prevented by a Gly618 to Val mutation in the alpha 1(X) NC1 domain resulting in Schmid metaphyseal chondrodysplasiaD Chan, W G Cole, J G Rogers, et al.
Anaesthesia and Intensive Care|August 1, 1996
Anaesthesia for children with mucopolysaccharidosesC Moores, J G Rogers, I M McKenzie, et al.
Teratology|February 1, 1986
Methacrylic acid as a teratogen in rat embryo cultureJ G Rogers, J C Greenaway, P E Mirkes, et al.
Journal of Paediatrics and Child Health|February 1, 1990
Five cases demonstrating the distinctive behavioural features of chromosome deletion 17(p11.2 p11.2) (Smith-Magenis syndrome)A F Colley, M A Leversha, L E Voullaire, et al.
Journal of Inherited Metabolic Disease|January 1, 1985
5,10-Methylenetetrahydrofolate reductase deficiency. Clinical and biochemical features of a further caseE A Haan, J G Rogers, G P Lewis, et al.
Toxicology and Applied Pharmacology|February 1, 1984
Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitroP E Mirkes, J C Greenaway, J G Rogers, et al.
Journal of Medical Genetics|September 1, 1990
The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissuesW G Cole, P E Campbell, J G Rogers, et al.
Journal of Medical Genetics|April 1, 1990
The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagenW G Cole, C W Chow, J G Rogers, et al.
Pageof 7